Titre du document / Document title
Neurologic complications of cancer therapy
Auteur(s) / Author(s)
PLOTKIN Scott R.
(1) ;
WEN Patrick Y.
(1 2) ;
Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)
(1) Department of Neurology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02446, ETATS-UNIS
(2) Center For Neuro-Oncology, SW430D, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, ETATS-UNIS
Résumé / Abstract
Neurologic complications of chemotherapy are relatively common. The diagnosis of chemotherapy-associated neurotoxicity remains a clinical one, and is largely based on the exclusion of other possible causes. The goal of this review is to describe the neurotoxicity associated with established chemotherapeutic agents and with some of the newer biologic agents, monoclonal antibodies and targeted molecular therapies used in the treatment of cancer.
Revue / Journal Title
Neurologic clinics
ISSN 0733-8619
Source / Source
2003, vol. 21, n
o 1 (374 p.) (239 ref.), [Note(s) : x, 279-318 [41 p.]]
Langue / Language
Anglais
Editeur / Publisher
Elsevier, Philadelphia, PA, ETATS-UNIS
(1983)
(Revue)
Mots-clés anglais / English Keywords
Monoclonal antibody ;
Toxicity ;
Diagnosis ;
Treatment ;
Complication ;
Nervous system diseases ;
Chemotherapy ;
Malignant tumor ;
Mots-clés français / French Keywords
Anticorps monoclonal ;
Toxicité ;
Diagnostic ;
Traitement ;
Complication ;
Système nerveux pathologie ;
Chimiothérapie ;
Tumeur maligne ;
Mots-clés espagnols / Spanish Keywords
Anticuerpo monoclonal ;
Toxicidad ;
Diagnóstico ;
Tratamiento ;
Complicación ;
Sistema nervioso patología ;
Quimioterapia ;
Tumor maligno ;
Localisation / Location
INIST-CNRS, Cote INIST : 21599, 35400010949288.0110
Nº notice refdoc (ud4) : 14673230
